# Safety and Efficacy Study of the BioVentrix PliCath HF System

Study · id `cardio:ct-nct01568164` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01568164](<https://clinicaltrials.gov/study/NCT01568164>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01568164

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 120 participants.

## Technical summary

Registry record NCT01568164. Allocation not applicable; no masking; primary purpose treatment. Start 2012-03 (registry gives no type); primary completion 2019-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT01568164, source copy `cardio:ctgov-nct01568164-2021-03-11`, retrieved 2026-10-26)
- Start date: 2012-03 (registry gives no type) (ClinicalTrials.gov record NCT01568164, source copy `cardio:ctgov-nct01568164-2021-03-11`, retrieved 2026-10-26)
- Primary completion: 2019-12 (actual) (ClinicalTrials.gov record NCT01568164, source copy `cardio:ctgov-nct01568164-2021-03-11`, retrieved 2026-10-26)
- Completion: 2019-12 (actual) (ClinicalTrials.gov record NCT01568164, source copy `cardio:ctgov-nct01568164-2021-03-11`, retrieved 2026-10-26)
- Countries: Austria; Czechia; France; Greece; Italy; Latvia; Lithuania; Poland; Portugal; Spain; United Kingdom (ClinicalTrials.gov record NCT01568164, source copy `cardio:ctgov-nct01568164-2021-03-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01568164-2021-03-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy Study of the BioVentrix PliCath HF System
- Acronym: CONFIGURE-HF
- Condition: Heart Failure
- Intervention (Device): PliCath HF System
- Lead sponsor: BioVentrix
- Lead sponsor class: INDUSTRY
- Collaborator: Ohio State University
- Collaborator class: OTHER
- Collaborator: CDI Centro Diagnostico Italiano S.p.A
- Collaborator class: OTHER
- Collaborator: Advance Research Associates
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as a collaborator: Ohio State University (`cardio:org-ohio-state-university`)
- Registry lists this organization as a collaborator: Advance Research Associates (`cardio:org-advance-research-associates`)

## Provenance

Content hash: 4fb53557d856ca6c7b5c1fd62defe9504d937d1c38eef9bbdd63ffdf2ff58ca7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
